From: Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer
Age < 70
Age ≥ 70
Total
1
(<1%)
0
2
7
(3%)
3
10
9
(4%)
(8%)
16
(5%)
4
13
(6%)
11
(12%)
24
5
188
(84%)
71
(76%)
259